Drug News Express | Zaiding Pharmaceuticals Introduces Small Molecule New Drugs for Alzheimer's Disease Approved for Clinical Use
海角七号
发表于 2024-3-4 10:07:02
246
0
0
On February 29th, according to the official website of the Drug Evaluation Center of the National Medical Products Administration, the Class 1 new drug KarXT capsules applied for by Karuna Company have obtained implied permission for clinical trials and are planned to be developed for the treatment of mental and behavioral symptoms related to Alzheimer's disease. Zaiding Pharmaceutical owns the development, production, and commercialization rights of KarXT in Greater China.
According to the medical Rubik's cube data, KarXT (xanomeline tropium) is an oral M1/M4 type muscarine acetylcholine receptor agonist developed by Karuna company. The approved clinical indication for this is Alzheimer's disease-related psychobehavioral symptoms.
Hang Seng Pharmaceutical ETF (159892) holds positions in well-known innovative pharmaceutical industry chain enterprises such as Zhongding Pharmaceutical, WuXi AppTec, WuXi AppTec, and BeiGene, with high R&D investment and strong innovation attributes. With the progress of domestic technology, overseas market business has also been steadily advancing in recent years.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Intel Technology is expected to complete $8.5 billion in financing by the end of the year; A total of 109 domestic online games were approved in September
- Can I choose SF Express on Taobao and Tmall? An additional 5 yuan postage fee is required! Double Eleven service roll up
- Dialogue with Express Overseas Warriors: Fighting in Southeast Asia, light assets or heavy investment? Where is the incremental space?
- Johnson&Johnson's drug Zebaike has been approved in China
- JD Express International launches delivery service to 7 Southeast Asian countries
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Abbott announces the launch of its new women's health drug Fenyouning in China
- Most of the popular Chinese concept stocks before the US stock market rose, while Zhongtong Express rose nearly 7%
- One week express delivery to sea | Dingdong Maicai launches first choice for sea travel to Saudi Arabia; SF Express Hong Kong Stock Listing Passes Hearing
-
知名做空机构香橼研究(Citron Research)周四(11月21日)在社交媒体平台X上发布消息称,该公司已决定做空“比特币大户”微策略(Microstrategy)这家公司,并认为该公司已经将自己变身成为一家比特币投资基金 ...
- caffycat
- 昨天 11:18
- 支持
- 反对
- 回复
- 收藏
-
每经AI快讯,11月20日,文远知行宣布旗下自动驾驶环卫车S6与无人扫路机S1分别在新加坡滨海湾海岸大道与滨海艺术中心正式投入运营。据介绍,这是新加坡首个商业化运营的自动驾驶环卫项目。 ...
- star8699
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者王子霖)11月20日,斗鱼发布2024年第三季度未经审计的财务报告。本季度斗鱼依托丰富的游戏内容生态,充分发挥主播资源和新业务潜力,持续为用户提供高质量的直播内容及游戏服务,进一步 ...
- goodfriendboy
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
人民网北京11月22日电 (记者栗翘楚、任妍)2024广州车展,在新能源汽车占据“半壁江山”的同时,正加速向智能网联新能源汽车全面过渡,随着“端到端”成为新宠,智能驾驶解决方案成为本届广州车展各大车企竞 ...
- 3233340
- 昨天 17:06
- 支持
- 反对
- 回复
- 收藏